US2006127271A1PendingUtilityA1
Non-thermal disinfection of biological fluids using non-thermal plasma
Est. expiryMay 7, 2021(expired)· nominal 20-yr term from priority
A61L 2/02A61L 2103/05B01J 2219/0896B01J 2219/0828B01J 2219/00038A61L 2/14B01J 2219/083B01J 2219/0869A61M 1/32A61M 2205/75A61M 1/3681B01J 19/088A61M 1/168B01J 2219/0877B01J 2219/0835A61M 1/1698B01J 2219/0809A61M 1/36H01J 37/32348H05H 1/24A23B 2/50H05H 2245/36H05H 1/246
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method and apparatus are provided for at least partially disinfecting biological fluid of a mammal, which comprises pathogens. The method includes contacting a non-thermal plasma with the biological fluid to kill at least a portion of the pathogens within the biological fluid, and filtering toxins from at least some components of the biological fluid.
Claims
exact text as granted — not AI-modified1 . A method of at least partially disinfecting biological fluid of a mammal, which comprises pathogens, the method comprising:
(a) drawing the biological fluid from the mammal; (b) contacting a non-thermal plasma with the biological fluid to kill at least a portion of the pathogens within the biological fluid; (c) filtering toxins from at least some components of the biological fluid after contacting in step (b); and (d) returning the biological fluid to the mammal after filtering the toxins in step (c).
2 . The method of claim 1 wherein:
step (a) comprises drawing the biological fluid from a blood circulatory system of the mammal; and step (d) comprises returning the biological fluid to the blood circulatory system.
3 . The method of claim 1 wherein:
step (a) comprises drawing the biological fluid from an organ of the mammal; and step (d) comprises returning the biological fluid to the organ.
4 . The method of claim 1 and further comprising:
(e) introducing gas bubbles into the biological fluid to generate liquid-gas mixture; and (f) contacting the liquid-gas mixture with the non-thermal plasma during step (b).
5 . The method of claim 4 and further comprising:
(g) removing the gas bubbles from the liquid-gas mixture after contacting in step (b) and before returning in step (d).
6 . The method of claim 5 and further comprising:
(h) passing the biological fluid through a gas detector after step (g) and prior to returning the biological fluid to the mammal in step (d).
7 . The method of claim 1 and further comprising:
(e) introducing a diluent into the biological fluid to generate a diluted biological fluid; and (f) treating the diluted biological fluid with the non-thermal plasma during step (b); and (g) filtering some of the diluent from the diluted biological fluid in step (c).
8 . The method of claim 1 wherein step (c) comprises passing the biological fluid along a semi-permeable membrane having pore sizes that filter toxins having selected sizes from larger components of the biological fluid.
9 . The method of claim 8 wherein the semi-permeable membrane comprises pore sizes of approximately 0.1 to 2 micrometers.
10 . The method of claim 1 wherein step (c) comprises filtering at least some blood-borne bacteria from at least some components of the biological fluid.
11 . A method of at least partially disinfecting biological fluid of a mammal, which comprises pathogens, the method comprising:
(a) contacting a non-thermal plasma with the biological fluid to kill at least a portion of the pathogens within the biological fluid; and (b) filtering toxins from at least some components of the biological fluid after contacting in step (a).
12 . The method of claim 11 wherein:
step (a) releases toxins from at least some of the pathogens; and step (b) comprises filtering the toxins released in step (a) from at least some components of the biological fluid.
13 . The method of claim 11 wherein step (b) comprises passing the biological fluid along a semi-permeable membrane having pore sizes that filter toxins having selected sizes from larger components of the biological fluid.
14 . The method of claim 13 wherein the semi-permeable membrane comprises pore sizes of approximately 0.1 to 2 micrometers.
15 . The method of claim 11 wherein step (b) comprises filtering at least some blood-borne bacteria from at least some components of the biological fluid.
16 . The method of claim 11 and further comprising:
(c) drawing the biological fluid from the mammal prior to step (a); and (d) returning the biological fluid to the mammal after filtering the toxins in step (b).
17 . The method of claim 16 wherein:
step (c) comprises drawing the biological fluid from a blood circulatory system of the mammal; and step (d) comprises returning the biological fluid to the blood circulatory system.
18 . The method of claim 16 wherein:
step (c) comprises drawing the biological fluid from an organ of the mammal; and step (d) comprises returning the biological fluid to the organ.
19 . The method of claim 11 and further comprising:
(c) introducing gas bubbles into the biological fluid to generate liquid-gas mixture prior to step (a); (d) contacting the liquid-gas mixture with the non-thermal plasma during step (a); and (e) removing the gas bubbles from the liquid-gas mixture after contacting in step (a).
20 . The method of claim 11 and further comprising:
(c) introducing a diluent into the biological fluid to generate a diluted biological fluid; (d) treating the diluted biological fluid with the non-thermal plasma during step (a); and (e) filtering some of the diluent from the diluted biological fluid in step (b).
21 . A liquid-gas mixture comprising a mammalian biological liquid, gas bubbles, and a non-thermal plasma.Join the waitlist — get patent alerts
Track US2006127271A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.